Drug Identification System

PillID

← Drug Encyclopedia 🌙

Uses & FDA Indications

Simvastatin is a widely prescribed moderate-intensity statin used to lower elevated cholesterol and triglycerides and to reduce the risk of major cardiovascular events. It is FDA-approved as an adjunct to dietary modification in adults with hyperlipidemia (high LDL, elevated total cholesterol, low HDL), mixed dyslipidemia, and hypertriglyceridemia.

The landmark 4S (Scandinavian Simvastatin Survival Study) and HPS (Heart Protection Study) trials established simvastatin's ability to significantly reduce mortality, coronary heart disease events, stroke, and revascularization procedures. On the basis of this evidence, simvastatin is approved to reduce the risk of cardiovascular events in patients with established coronary artery disease or at high risk for CHD, including those with diabetes or peripheral arterial disease.

• Primary hyperlipidemia and mixed dyslipidemia (adjunct to diet)
• Hypertriglyceridemia
• Heterozygous familial hypercholesterolemia (including adolescents)
• Homozygous familial hypercholesterolemia
• Cardiovascular risk reduction in established CHD or high-risk patients

How It Works

Simvastatin is a prodrug — administered as an inactive lactone that is hydrolyzed in vivo to its active beta-hydroxy acid form. This active metabolite competitively inhibits HMG-CoA reductase, the enzyme that catalyzes the conversion of HMG-CoA to mevalonate — the rate-limiting step in cholesterol biosynthesis. Reduced hepatic cholesterol production triggers upregulation of LDL receptors on liver cell surfaces, which in turn accelerates clearance of LDL particles from the blood.

Simvastatin is extensively metabolized by CYP3A4 in the liver and intestinal wall. This metabolic dependence on CYP3A4 is important clinically, because drugs that inhibit CYP3A4 can dramatically raise simvastatin blood levels and the risk of severe muscle toxicity.

Side Effects

Common

• Myalgia — muscle aches and pain (most common reason for discontinuation)
• Headache
• Nausea, stomach pain, constipation
• Upper respiratory infections
• Asthenia (weakness)
• Mild, transient liver enzyme elevations

Serious

• Myopathy — significant muscle pain, tenderness, or weakness with elevated creatine phosphokinase (CPK)
• Rhabdomyolysis — life-threatening muscle breakdown; risk highest at high exposures and with interacting drugs
• Statin-associated autoimmune myopathy (IMNM) — rare; persists after stopping statin
• Hepatotoxicity — rare but serious elevation in liver enzymes; obtain baseline LFTs before initiating
• New-onset type 2 diabetes mellitus
• Cognitive effects — rare memory disturbances and confusion (reversible)

Drug Interactions

Drug / Class	Interaction	Clinical Significance
Strong CYP3A4 inhibitors (itraconazole, ketoconazole, clarithromycin, erythromycin, HIV protease inhibitors, nefazodone)	Markedly increase simvastatin plasma levels; risk of severe myopathy and rhabdomyolysis	Contraindicated — do not co-administer
Gemfibrozil	Inhibits simvastatin metabolism and increases systemic exposure; high rhabdomyolysis risk	Contraindicated — use fenofibrate instead if lipid combination needed
Cyclosporine and danazol	Both contraindicated with simvastatin due to greatly increased muscle toxicity risk	Contraindicated
Amiodarone, verapamil, diltiazem, amlodipine	Moderate CYP3A4 inhibition; increase simvastatin levels; risk of myopathy at higher simvastatin exposures — dose limits apply per FDA labeling	High — dose limits mandated by FDA
Warfarin	Simvastatin potentiates warfarin anticoagulant effect; INR may increase	High — monitor INR when starting, changing dose, or stopping simvastatin
Grapefruit juice	Inhibits intestinal CYP3A4; significantly raises simvastatin blood levels and myopathy risk	High — avoid grapefruit and grapefruit juice
Niacin (high-dose, ≥1 g/day)	Additive myopathy risk, particularly in Chinese patients	Moderate — use lowest effective doses; caution in Asian patients

Warnings & Contraindications

• Contraindicated: Active liver disease or unexplained persistent elevation of liver enzymes; pregnancy; breastfeeding; concurrent use of strong CYP3A4 inhibitors, gemfibrozil, cyclosporine, or danazol
• FDA dose restriction (2011): The highest available simvastatin strength carries an elevated myopathy risk and should not be prescribed to new patients; patients on it who are stable may continue if monitored
• Chinese patients / niacin: The combination of simvastatin with high-dose niacin is associated with disproportionately higher myopathy risk in patients of Chinese origin
• Hypothyroidism: Untreated hypothyroidism increases myopathy risk with any statin — screen and treat before initiating
• Age and renal impairment: Older adults and those with severe renal impairment have higher simvastatin exposure and greater myopathy risk; careful monitoring is essential

Frequently Asked Questions

Why do I have to take simvastatin at night?

The liver produces most of its cholesterol during the overnight hours. Simvastatin has a relatively short half-life of about 2–3 hours for its active metabolite, meaning drug levels peak and then decline fairly quickly. Taking it in the evening or at bedtime aligns peak drug activity with the period of highest cholesterol synthesis, resulting in greater LDL reduction compared to morning dosing. Longer-acting statins like rosuvastatin or atorvastatin are less time-dependent.

Can I drink grapefruit juice while taking simvastatin?

No. Grapefruit and grapefruit juice contain compounds (furanocoumarins) that irreversibly inhibit CYP3A4 in the gut wall — the primary enzyme responsible for breaking down simvastatin during absorption. Even a single glass of grapefruit juice can substantially raise simvastatin blood levels, increasing the risk of myopathy and potentially rhabdomyolysis. This restriction applies throughout therapy, not just around the time of your dose.

Is simvastatin becoming less commonly prescribed?

Yes, prescribing has shifted in recent years. The FDA's 2011 safety communication restricted high-strength simvastatin use due to its elevated myopathy risk profile compared to other statins. High-intensity statins like atorvastatin and rosuvastatin have been shown to achieve greater LDL reductions with comparable or more manageable drug interaction profiles. Current ACC/AHA cholesterol guidelines now preferentially recommend high-intensity statins for patients at higher cardiovascular risk, leading many prescribers to choose alternatives.

What should I do if I experience muscle pain on simvastatin?

Mild, generalized muscle aches are common in statin users, often unrelated to actual muscle injury. However, if you experience significant muscle pain, tenderness, weakness — especially diffuse — or notice dark or tea-colored urine, seek medical attention promptly. These symptoms may indicate myopathy or the rare but serious condition of rhabdomyolysis. Your healthcare provider will check a blood test (CPK/CK) and evaluate whether the medication should be adjusted or stopped.

→ Statin Side Effects Guide → High Cholesterol Medications Guide